1109 related articles for article (PubMed ID: 29474715)
1. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
3. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: follow-up data from the PREFER in AF European Registry].
Renda G; Patti G; Sangiuolo R; Attena E; Malpezzi MG; De Caterina R;
G Ital Cardiol (Rome); 2016 Nov; 17(11):922-931. PubMed ID: 27996998
[TBL] [Abstract][Full Text] [Related]
4. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
7. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
8. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (
Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385
[TBL] [Abstract][Full Text] [Related]
13. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).
Thind M; Holmes DN; Badri M; Pieper KS; Singh A; Blanco RG; Steinberg BA; Fonarow GC; Gersh BJ; Mahaffey KW; Peterson ED; Reiffel JA; Piccini JP; Kowey PR;
Am J Cardiol; 2018 Nov; 122(10):1677-1683. PubMed ID: 30227964
[TBL] [Abstract][Full Text] [Related]
14. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
[TBL] [Abstract][Full Text] [Related]
16. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
19. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
[TBL] [Abstract][Full Text] [Related]
20. Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
Steensig K; Olesen KKW; Thim T; Nielsen JC; Jensen SE; Jensen LO; Kristensen SD; Bøtker HE; Lip GYH; Maeng M
Thromb Haemost; 2018 Dec; 118(12):2162-2170. PubMed ID: 30419601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
